Key Takeaways
- • Hamilton Lane (HLNE) is scheduled to release Q4 fiscal 2026 and full-year results for the period ended March 31, 2026, with earnings date confirmed for May 21, 2026.
- • Q3 2026 earnings, reported February 3, 2026, delivered EPS of $1.55, beating consensus estimates of $1.28 by $0.27, demonstrating consistent earnings beat performance.
- • Stock currently trades at $85.16 (as of May 15, 2026) with a 52-week range of $84.08–$179.19; analyst consensus rating is Buy with average 12-month price target of $155.38, implying 74.58% upside from current levels.
- • Company maintains strong profitability metrics: 30.59% profit margin, 31.70% return on equity (TTM), and trailing EPS of $5.61; market capitalization stands at approximately $3.9–$4.75 billion.
- • Morgan Stanley maintains Equal-Weight rating as of April 21, 2026, lowering price target from $159 to $141, while the broader analyst consensus (8 analysts) leans constructive with 50% Buy and 13% Strong Buy recommendations.
Summary
Hamilton Lane Incorporated (Nasdaq: HLNE), a leading provider of private markets investment solutions, is set to report fourth-quarter fiscal 2026 and full-year financial results for the period ended March 31, 2026, on May 21, 2026. This upcoming earnings announcement will provide investors with comprehensive insight into the firm's performance across its private equity, private credit, and other alternative investment platforms.
The company has demonstrated solid earnings momentum heading into this report. In Q3 2026, reported on February 3, Hamilton Lane delivered earnings per share of $1.55, surpassing the consensus analyst estimate of $1.28 by $0.27—a notable 21% beat that underscores execution strength in a competitive alternative asset management environment. This consistent outperformance relative to expectations positions the stock favorably for the upcoming full-year disclosure.
From a valuation and technical perspective, HLNE traded at $85.16 as of May 15, 2026, down 2.80% on the day, with a 52-week trading range of $84.08 to $179.19. The stock's fundamental metrics reflect a mature, profitable alternative asset manager: trailing earnings per share of $5.61, a profit margin of 30.59%, and return on equity of 31.70% (TTM). At a trailing P/E ratio of 15.18, the stock commands a reasonable valuation relative to its profitability profile. Analyst coverage spans eight institutions, with consensus leaning constructive: 50% recommend Buy, 13% Strong Buy, and 38% Hold. The average 12-month price target stands at $155.38, representing 74.58% upside from May 15 levels. Morgan Stanley, however, maintained an Equal-Weight rating on April 21, 2026, lowering its target from $159 to $141, reflecting a more cautious stance despite acknowledging management quality and industry positioning.
Hamilton Lane's balance sheet remains well-capitalized with $338.5 million in total cash (most recent quarter) and an enterprise value of approximately $3.93 billion. Forward dividend yield of 2.54% and a normalized annual dividend of $2.16 per share provide income-oriented investors with an additional return component. The firm's business model—serving institutional and high-net-worth clients in private markets—continues to benefit from secular flows into alternative assets, though valuation multiples reflect the market's current appetite for alternative asset managers at this stage of the market cycle.
The company has demonstrated solid earnings momentum heading into this report. In Q3 2026, reported on February 3, Hamilton Lane delivered earnings per share of $1.55, surpassing the consensus analyst estimate of $1.28 by $0.27—a notable 21% beat that underscores execution strength in a competitive alternative asset management environment. This consistent outperformance relative to expectations positions the stock favorably for the upcoming full-year disclosure.
From a valuation and technical perspective, HLNE traded at $85.16 as of May 15, 2026, down 2.80% on the day, with a 52-week trading range of $84.08 to $179.19. The stock's fundamental metrics reflect a mature, profitable alternative asset manager: trailing earnings per share of $5.61, a profit margin of 30.59%, and return on equity of 31.70% (TTM). At a trailing P/E ratio of 15.18, the stock commands a reasonable valuation relative to its profitability profile. Analyst coverage spans eight institutions, with consensus leaning constructive: 50% recommend Buy, 13% Strong Buy, and 38% Hold. The average 12-month price target stands at $155.38, representing 74.58% upside from May 15 levels. Morgan Stanley, however, maintained an Equal-Weight rating on April 21, 2026, lowering its target from $159 to $141, reflecting a more cautious stance despite acknowledging management quality and industry positioning.
Hamilton Lane's balance sheet remains well-capitalized with $338.5 million in total cash (most recent quarter) and an enterprise value of approximately $3.93 billion. Forward dividend yield of 2.54% and a normalized annual dividend of $2.16 per share provide income-oriented investors with an additional return component. The firm's business model—serving institutional and high-net-worth clients in private markets—continues to benefit from secular flows into alternative assets, though valuation multiples reflect the market's current appetite for alternative asset managers at this stage of the market cycle.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.